On September 1, 2020 Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) reported that the Company will be presenting a corporate overview at the following investor conferences in September (Press release, Oncolytics Biotech, SEP 1, 2020, View Source [SID1234564233]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

LD Micro 500 Virtual Investor Conference

Presenter: Dr. Matt Coffey, President and Chief Executive Officer of Oncolytics Biotech Inc.
Date: Thursday, September 3, 2020
Time: 4:20 pm ET
Webcast Link: Available here

H.C. Wainwright 22nd Annual Global Investment Conference

Presenter: Dr. Matt Coffey, President and Chief Executive Officer of Oncolytics Biotech Inc.
Date: Tuesday, September 15, 2020
Time: 2:00 pm ET
Webcast Link: Available here

Company management will also be participating in one-on-one investor meetings at both conferences. To schedule a meeting please submit a meeting request on the website for each respective conference, or email [email protected].

Live webcasts of the Company’s presentations will also be available on the Investor Relations page of Oncolytics’ website (LINK) and will be archived for three months.